• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall cobas infinity central lab / cobas infinity core license

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall cobas infinity central lab / cobas infinity core license see related information
Date Initiated by Firm June 24, 2021
Create Date September 10, 2021
Recall Status1 Terminated 3 on July 21, 2023
Recall Number Z-2444-2021
Recall Event ID 88398
Product Classification Calculator/data processing module, for clinical use - Product Code JQP
Product cobas infinity central lab running software version 3.01.03 through 3.02.08, Catalog#: 07154003001
Code Information UDI: 04015630936007; All systems running software version 3.01.03 - 3.02.08
Recalling Firm/
Manufacturer
Roche Diagnostics Operations, Inc.
9115 Hague Rd
Indianapolis IN 46256-1025
Manufacturer Reason
for Recall
Under specific circumstances created by the user, the cobas e flow test results could be replaced by an automatic result sent to the lab LIS. This automatic result could be released and interpreted by your Laboratory Information System (LIS) as a false positive or negative result. It should be noted that the "correct" result would still be available on the instrument.
FDA Determined
Cause 2
Software design
Action An Urgent Medical Device Correction notification letter dated 6/24/21 was sent to customers. Actions Required " Follow the Workaround section of this Urgent Medical Device Correction (UMDC), if applicable. " Consult with the physician or pathologist at your facility to determine any clinical implications specific to your patients. " Until the service patch is available, use the workaround described in this UMDC. " Complete all sections of the enclosed faxback form (TP-01337) and fax it to 1-847-457-1389 or email it to roche6071@stericycle.com. " File this UMDC for future reference. Identifying the Issue This issue occurs under specific circumstances and ALL of the conditions listed in the Issue section on page one of this UMDC must be fulfilled in order for the issue to occur. The issue can be identified when: " the current result appears as a repetition in the validation screen, " the Raw result column will appear blank indicating that the current result was not received from the instrument, and " the test alarm REP is triggered that indicates that the test results were repeated. Also, the issue can be detected in the validation screen based on the information that might be shown. The list below may help identify the issue (depending on your system configuration): " The LIS test result differs from the analyzer result. " There is a test alarm indicating the result is a repetition. " There is no analyzer associated with the result. " The main result time differs from some or all of the embedded result times. " The Preliminary result column displays the previous result, which corresponds to the original result sent by the instrument. " The repetition icon indicates the number of repetitions (i.e., 1 or more). Workaround Roche recommends contacting the Roche Support Network Customer Support Center at 1-800-526-2272 to request support for the workaround listed below: The following workaround can be used until the service patches are available to resolve this i
Quantity in Commerce 2058 licenses worldwide, 79 licenses in US
Distribution US Nationwide distribution
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-